These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 22103762)
1. Industry funded clinical trials: bias and quality. Del Parigi A Curr Med Res Opin; 2012 Jan; 28(1):23-5. PubMed ID: 22103762 [TBL] [Abstract][Full Text] [Related]
2. Biased articles. Friedman JH Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378 [No Abstract] [Full Text] [Related]
3. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review. Tereskerz PM Account Res; 2003; 10(3):137-58. PubMed ID: 14979317 [No Abstract] [Full Text] [Related]
4. Implications of pharmaceutical industry funding on clinical research. Lexchin JR Ann Pharmacother; 2005 Jan; 39(1):194-7. PubMed ID: 15562137 [TBL] [Abstract][Full Text] [Related]
5. Independent medical research. van der Meer JW; de Gier AM; van Swaaij WP; Katan MB Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759 [No Abstract] [Full Text] [Related]
6. Medical ethics, research and the pharmaceutical industry. Abud-Mendoza C Reumatol Clin; 2012; 8(5):233-5. PubMed ID: 22608694 [No Abstract] [Full Text] [Related]
7. Bias in the design, interpretation, and publication of industry-sponsored clinical research. Hammerschmidt D Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022 [No Abstract] [Full Text] [Related]
9. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting. Williams KM Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925 [No Abstract] [Full Text] [Related]
10. Small study on industry trial sponsorship leads to big questions about quality and bias. Twombly R J Natl Cancer Inst; 2007 Jul; 99(13):988-90. PubMed ID: 17596566 [No Abstract] [Full Text] [Related]
11. The potential for bias in reporting of industry-sponsored clinical trials. Pyke S; Julious SA; Day S; O'Kelly M; Todd S; Matcham J; Seldrup J Pharm Stat; 2011; 10(1):74-9. PubMed ID: 21275037 [TBL] [Abstract][Full Text] [Related]
12. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials. Lachin JM Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730 [TBL] [Abstract][Full Text] [Related]
13. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward. Samson K Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337 [No Abstract] [Full Text] [Related]
14. An analysis of the clinical development of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry. Winther FO; Hole OP; Nitter-Hauge S Eur J Clin Pharmacol; 2007 Oct; 63(10):909-12. PubMed ID: 17673994 [TBL] [Abstract][Full Text] [Related]
15. Sponsorship bias in clinical research. Lexchin J Int J Risk Saf Med; 2012; 24(4):233-42. PubMed ID: 23135338 [TBL] [Abstract][Full Text] [Related]
16. The perverse consequences of a proposed global tax on research. MacDonald C; Walton N Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972 [No Abstract] [Full Text] [Related]
17. Conflicts of interest with the health industry. Dubois MY Pain Med; 2006; 7(5):463-5. PubMed ID: 17014609 [No Abstract] [Full Text] [Related]
18. Medicine in the Noise Age: what can we believe? Angell M Account Res; 2001; 8(3):189-95. PubMed ID: 12481786 [No Abstract] [Full Text] [Related]
19. Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research. Tereskerz PM; Moreno J Account Res; 2005; 12(2):139-55. PubMed ID: 16220626 [TBL] [Abstract][Full Text] [Related]